Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary roundtable conducted by the FDA in front of its recently-appointed top ...

Victoria Gray is the first person in the world to receive CRISPR,  a gene-editing therapy for sickle cell disease created by ...

Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on ...

KJ Muldoon, a 10-month-old baby, was diagnosed with the genetic disease carbamoyl-phosphate synthetase 1 deficiency after he ...

Beam Therapeutics BEAM announced that the FDA has granted an orphan drug designation to its investigational genome-editing ...

Genetic screening technology now allows parents employing in vitro fertilization (IVF) to select for certain traits, allowing ...

A baby born with a rare and dangerous genetic disease is thriving after getting an experimental gene editing treatment made ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.

Two groundbreaking biotechnology advances are fundamentally altering human health and food production in 2025, moving from ...

Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...